T1	Person 0 3	Age
T2	Value 7 17	= 18 years
R1	Has_value Arg1:T1 Arg2:T2	
T3	Observation 29 66	able to give written informed consent
T4	Qualifier 69 75	Active
T5	Qualifier 76 83	chronic
T6	Condition 84 123	central serous chorioretinopathy (cCSC)
R2	Has_qualifier Arg1:T6 Arg2:T5	
R3	Has_qualifier Arg1:T6 Arg2:T4	
T7	Condition 126 148	Subjective visual loss
T8	Temporal 149 158	> 6 weeks
R4	Has_temporal Arg1:T7 Arg2:T8	
T9	Non-representable 160 199	interpreted as onset of active disease;
T10	Condition 201 230	Foveal subretinal fluid (SRF)
T11	Procedure 235 269	optical coherence tomography (OCT)
R5	AND Arg1:T11 Arg2:T10	
T12	Temporal 271 294	at Baseline Examination
R6	Has_temporal Arg1:T11 Arg2:T12	
T13	Reference_point 274 294	Baseline Examination
R7	Has_index Arg1:T12 Arg2:T13	
T14	Multiplier 297 299	=1
T15	Qualifier 300 311	ill-defined
T16	Condition 312 342	hyperfluorescent leakage areas
R8	Has_qualifier Arg1:T16 Arg2:T15	
R9	Has_multiplier Arg1:T16 Arg2:T14	
T17	Procedure 346 374	fluorescein angiography (FA)
R10	AND Arg1:T17 Arg2:T16	
T18	Condition 380 423	retinal pigment epithelial window defect(s)
R11	AND Arg1:T17 Arg2:T18	
T19	Non-representable 424 453	that are compatible with cCSC
T20	Condition 456 478	Hyperfluorescent areas
T21	Procedure 482 518	indocyanine green angiography (ICGA)
R12	AND Arg1:T21 Arg2:T20	
